BANK OF MONTREAL /CAN/ - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 81 filers reported holding TG THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 8.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,285,319
-14.6%
127,933
-60.6%
0.00%0.0%
Q4 2022$3,847,183
+260.6%
324,931
+91.4%
0.00%
Q3 2022$1,067,000
+46.2%
169,752
+2.0%
0.00%
Q2 2022$730,000
-55.4%
166,351
+0.1%
0.00%
Q1 2022$1,636,000
+6.9%
166,158
+113.6%
0.00%
-100.0%
Q4 2021$1,530,000
-71.0%
77,777
-50.1%
0.00%
-50.0%
Q3 2021$5,267,000
+69.1%
155,976
+97.4%
0.00%0.0%
Q2 2021$3,115,000
+895.2%
79,008
+1078.3%
0.00%
Q1 2021$313,000
-69.8%
6,705
-66.1%
0.00%
-100.0%
Q4 2020$1,038,000
+587.4%
19,760
+276.0%
0.00%
Q3 2020$151,000
-23.7%
5,255
-36.1%
0.00%
Q2 2020$198,000
+54.7%
8,221
-28.8%
0.00%
Q4 2019$128,000
+172.3%
11,547
+37.0%
0.00%
Q3 2019$47,000
-32.9%
8,427
+3.5%
0.00%
Q2 2019$70,000
+1300.0%
8,143
+1119.0%
0.00%
Q1 2019$5,000
+25.0%
668
-24.0%
0.00%
Q4 2018$4,000
+100.0%
879
+101.6%
0.00%
Q3 2018$2,000
-71.4%
436
-16.2%
0.00%
Q2 2018$7,000
+600.0%
520
+420.0%
0.00%
Q1 2018$1,0000.0%1000.0%0.00%
Q4 2017$1,000
-99.8%
100
-99.7%
0.00%
Q1 2017$443,000
+14666.7%
38,000
+11628.4%
0.00%
Q1 2016$3,000
-72.7%
324
-63.6%
0.00%
Q4 2015$11,000
+175.0%
891
+93.7%
0.00%
Q2 2014$4,000
-94.7%
460
-95.7%
0.00%
Q1 2014$75,00010,8000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders